MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2024.04.053

Медицинская библиотека · Journal of the American College of Cardiology · 2024

Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.

Batista Jose L, Liu Yuxi, Butler Javed, Del Prato Stefano, Ezekowitz Justin A, Lam Carolyn S P, Marwick Thomas H, Rosenstock Julio, Tang W H Wilson, Perfetti Riccardo, Urbinati Alessia, Zannad Faiez, Januzzi James L, Ibrahim Nasrien E

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Diabetic cardiomyopathy (DbCM) increases risk of overt heart failure in individuals with diabetes mellitus. Racial and ethnic differences in DbCM remain unexplored.

OBJECTIVES

The authors sought to identify racial and ethnic differences among individuals with type 2 diabetes mellitus, structural heart disease, and impaired exercise capacity.

METHODS

The ARISE-HF (Aldolase Reductase Inhibitor for Stabilization of Exercise Capacity in Heart Failure) trial is assessing the efficacy of an aldose reductase inhibitor for exercise capacity preservation in 691 persons with DbCM. Baseline characteristics, echocardiographic parameters, and functional capacity were analyzed and stratified by race and ethnicity.

RESULTS

The mean age of the study participants was 67.4 years; 50% were women. Black and Hispanic patients had lower use of diabetes mellitus treatments. Black patients had poorer baseline ventricular function and more impaired global longitudinal strain. Overall, health status was preserved, based on Kansas City Cardiomyopathy Questionnaire scores, but reduced exercise capacity was present as evidenced by reduced Physical Activity Scale for the Elderly (PASE) scores. When stratified by race and ethnicity and compared with the entire cohort, Black patients had poorer health status, more reduced physical activity, and a greater impairment in exercise capacity during cardiopulmonary exercise testing, whereas Hispanic patients also displayed compromised cardiopulmonary exercise testing functional capacity. White patients demonstrated higher physical activity and functional capacity.

CONCLUSIONS

Racial and ethnic differences exist in baseline characteristics of persons affected by DbCM, with Black and Hispanic study participants demonstrating higher risk features. These insights inform the need to address differences in the population with DbCM. (Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy [ARISE-HF]; NCT04083339).

Для цитирования: Batista Jose L, Liu Yuxi, Butler Javed, Del Prato Stefano, Ezekowitz Justin A, Lam Carolyn S P, Marwick Thomas H, Rosenstock Julio, Tang W H Wilson, Perfetti Riccardo, Urbinati Alessia, Zannad Faiez, Januzzi James L, Ibrahim Nasrien E. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.. Journal of the American College of Cardiology. 2024. DOI: 10.1016/j.jacc.2024.04.053.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.